SLE Clinical Trial - Choosing Tests Wisely in Rheumatology

Status Completed

Clinical Trial Summary

This is a randomized study intended to produce a reduction in ordering of inappropriate tests by general practitioners as determined by recommendations from the CRA's Choosing Wisely guidelines. This reduction of inappropriate testing is expected in referrals to the rheumatologists randomized to the intervention group. This study will further explore which recommendations from the Canadian Rheumatology Association (CRA)/Canada Choosing Wisely campaign have the most impact on regional referring physicians to the Rheumatology clinic at St. Joseph's Hospital, London.

Clinical Trial Description

This a randomized study in that 6 rheumatologists (30 referrals each) will be randomized to one of two groups: intervention or control. Referring physicians to the intervention group will be faxed a brief Choosing Wisely form (intervention) based upon the recommendations of the Canadian Rheumatology Association's (CRA) Canada Choosing Wisely campaign, while referring physicians from the control group will not receive the form (non intervention). Analysis will be based upon the results of a three question survey faxed to all referring physicians at year one and at year two and on future referrals from the referring physicians to determine if there is a reduction in the group of ordering physicians that received the intervention (Choosing Wisely form). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03240536
Study type	Interventional
Source	Lawson Health Research Institute
Contact
Status	Completed
Phase	N/A
Start date	May 15, 2018
Completion date	September 8, 2021

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05479071` - Relation of Antibodies Against Oxidized Low Density Lipoproteins to Disease Activity and Cardiovascular Affection in Systemic Lupus.
Completed	`NCT02240888` - Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response	N/A
Active, not recruiting	`NCT05748925` - Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis Patients	Phase 4
Not yet recruiting	`NCT04517240` - A Study on Protein Losing Enteropathy In Systemic Lupus Erythematosus
Completed	`NCT00710021` - Vitamin D3 in Systemic Lupus Erythematosus	Phase 2
Terminated	`NCT01946880` - Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)	Phase 2
Active, not recruiting	`NCT04018222` - Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
Completed	`NCT04368299` - Telemedicine for Follow-up of Systemic Lupus Erythematosus	N/A
Active, not recruiting	`NCT04037293` - Premature Atherosclerosis in Systemic Lupus Erythematosus
Not yet recruiting	`NCT04234633` - Effect of Gender on Clinical Presentation of SLE ِAt Assiut University Hospitals
Completed	`NCT01207297` - Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis	Phase 1
Terminated	`NCT00152555` - Physical Therapy for Systemic Lupus Erythematosus (SLE)	N/A
Recruiting	`NCT05822219` - Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases	N/A
Completed	`NCT04806113` - COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases	Phase 3
Recruiting	`NCT05966480` - Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus	Phase 2
Completed	`NCT03155477` - Effect Of Curcuma Xanthorrhiza and Vitamin D3 Supplementation in SLE Patients With Hypovitamin D	N/A
Recruiting	`NCT05342285` - Flow Mediated Dilation in Association With Hyperuricemia
Not yet recruiting	`NCT03984227` - New Signaling Pathway Targeting Systemic Lupus Erythematosus
Enrolling by invitation	`NCT03144063` - Improving the Assessment of SLE Disease Activity	N/A
Active, not recruiting	`NCT01761422` - Myocardial Inflammation in Systemic Lupus Erythematosus